Gene · 249
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Baohuoside I inhibits FXR signaling pathway to interfere with bile acid homeostasis via targeting ER α degradation. | Cell Biol Toxicol | 2023 | 35802278 | PubTator, text mining | PubMed |
| The inhibition of mineralisation by fibroblast growth factor 2 is associated with the altered expression of genes regulating phosphate balance. | Aust Endod J | 2023 | 35801357 | PubTator, text mining | PubMed |
| A Bone Histomorphometric Analysis of Hypophosphatasia-related Osteoporosis after Teriparatide Treatment. | Intern Med | 2023 | 35650135 | PubTator, text mining | PubMed |
| Rapid Prototypable Biomimetic Peristalsis Bioreactor Capable of Concurrent Shear and Multi-Axial Strain. | Cells Tissues Organs | 2023 | 35008089 | PubTator, text mining | PubMed |
| Ckmt1 is Dispensable for Mitochondrial Bioenergetics Within White/Beige Adipose Tissue. | Function (Oxf) | 2022 | 37954502 | PubTator, text mining | PubMed |
| Circulating Endothelial Progenitor and Mesenchymal Stromal Cells as Biomarkers for Monitoring Disease Status and Responses to Exercise. | Rev Cardiovasc Med | 2022 | 37680455 | PubTator, text mining | PubMed |
| Galloylated proanthocyanidins in dentin matrix exhibit biocompatibility and induce differentiation in dental stem cells. | J Bioact Compat Polym | 2022 | 37465414 | PubTator, text mining | PubMed |
| Epidermolysis Bullosa and Rickets in a 21-Year-Old Female: A Case Report. | Case Rep Dermatol | 2022 | 36824157 | PubTator, text mining | PubMed |
| Skeletal stem cells: origins, definitions, and functions in bone development and disease. | Life Med | 2022 | 36811112 | PubTator, text mining | PubMed |
| Skeletal diseases caused by mutations in PTH1R show aberrant differentiation of skeletal progenitors due to dysregulation of DEPTOR. | Front Cell Dev Biol | 2022 | 36726589 | PubTator, text mining | PubMed |
| Spinal meningiomas, from biology to management - A literature review. | Front Oncol | 2022 | 36713513 | PubTator, text mining | PubMed |
| Improved Protocol to Study Osteoblast and Adipocyte Differentiation Balance. | Biomedicines | 2022 | 36672539 | PubTator, text mining | PubMed |
| Iron Oxide Nanoparticles: A Review on the Province of Its Compounds, Properties and Biological Applications. | Materials (Basel) | 2022 | 36614400 | PubTator, text mining | PubMed |
| Childhood Hypophosphatasia Associated with a Novel Biallelic ALPL Variant at the TNSALP Dimer Interface. | Int J Mol Sci | 2022 | 36613725 | PubTator, text mining | PubMed |
| High-Phosphate-Stimulated Macrophage-Derived Exosomes Promote Vascular Calcification via let-7b-5p/TGFBR1 Axis in Chronic Kidney Disease. | Cells | 2022 | 36611957 | PubTator, text mining | PubMed |
| Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells. | Ther Adv Hematol | 2022 | 36601635 | PubTator, text mining | PubMed |
| Elucidating the mechanism of Hongjinshen decoction in the treatment of pulmonary fibrosis based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595795 | PubTator, text mining | PubMed |
| The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595750 | PubTator, text mining | PubMed |
| Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking. | Comput Math Methods Med | 2022 | 36590764 | PubTator, text mining | PubMed |
| RANKL neutralisation prevents osteoclast activation in a human in vitro ameloblastoma-bone model. | J Tissue Eng | 2022 | 36582941 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/249/papers?page=33